chevron_leftBack
As of 16 June 2026, JW Lifescience Corp. has a market cap of $132.19M USD, ranking #23697 globally and #1057 in South Korea.
It ranks #2128 in the Healthcare sector, and #771 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$132.19MUSD
200.22B KRW
Enterprise Value
$158.3MUSD
240.3B KRW
Revenue (TTM)
$170.23MUSD
257.83B KRW
EBITDA (TTM)
$33.88MUSD
51.44B KRW
Net Income (TTM)
$18.89MUSD
28.61B KRW
EBITDA Margin
20%
Profit Margin
11%
PE Ratio
7.0
PS Ratio
0.8
PB Ratio
0.9
EV/EBITDA
4.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Sungnam Cha
open_in_new
Employees
297
Founded
1994
Website
jw-lifescience.co.kr
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.3% | 0.6% | -2.7% | -0.9% | -4.9% | 13% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
234080
제이더블유생명과학(주)
ISIN: KR7234080000
Shares Out.:
Shares Outstanding:
15.485M1
Shares Float:
8.817M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
12,930 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About JW Lifescience Corp.
JW Lifescience Corporation provides national infusion solutions in South Korea and internationally. The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin-si, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 0126Z0
|
$9.18B
7K%
13.91T KRW
|
-
|
|
KRX: 000250
|
$6.8B
5K%
10.3T KRW
|
1958.1
|
|
KRX: 326030
|
$5.26B
4K%
7.97T KRW
|
29.9
|
|
KRX: 298380
|
$4.98B
4K%
7.55T KRW
|
-
|
|
KRX: 000100
|
$4.57B
3K%
6.92T KRW
|
35.9
|
|
KRX: 141080
|
$4.46B
3K%
6.76T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
576K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
414K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
273K%
|
97.4
|
|
SIX: RO
|
$322.73B
244K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.3B
219K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$275.68B
208K%
218.9B CHF
|
20.5
|
chevron_leftBack